Feasibility Tests for Various Prism Configurations for Visual Field Loss
NCT ID: NCT04424979
Last Updated: 2025-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
20 participants
INTERVENTIONAL
2020-11-06
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Test of Virtual Reality Obstacle Detection for Low Vision Walking
NCT05141604
Multisensory Rehabilitation of Hemianopia
NCT04963075
Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage
NCT05098236
Improving Visual Field Deficits With Noninvasive Brain Stimulation
NCT05085210
Understanding Visual Confusion Using Stereoscopic Displays
NCT04957745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High power prisms
Various configurations of high power prisms will be developed for each individual and custom fit into spectacles lenses.
High power prisms
High power prisms designed to shift images from blind areas into portions of the wearer's remaining, seeing, field of vision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High power prisms
High power prisms designed to shift images from blind areas into portions of the wearer's remaining, seeing, field of vision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visual acuity of at least 20/50 in the better eye
* In sufficiently good health to be able to complete sessions lasting 2-4 hours
* Able to independently walk short distances
* Able to give voluntary, informed consent
* Able to speak English
Exclusion Criteria
* A history of seizures in the last 6 months
* Hemispatial neglect (subjects with hemianopic field loss only)
7 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Eye Institute (NEI)
NIH
Massachusetts Eye and Ear Infirmary
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandra Bowers
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eliezer Peli, MSc, OD
Role: STUDY_DIRECTOR
Schepens Eye Research Institute of Massachusetts Eye and Ear
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schepens Eye Research Institute
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Bowers AR, Manda S, Shekar S, Hwang AD, Jung JH, Peli E. Pilot study of a pedestrian collision detection test for a multisite trial of field expansion devices for hemianopia. Optom Vis Sci. 2024 Jun 1;101(6):408-416. doi: 10.1097/OPX.0000000000002152.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MPP_Feasibility1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.